The World Health Organization has approved a version of a widely used cholera vaccine that could help address a surge in cases that has depleted the global vaccine stockpile and left poorer countries scrambling to contain epidemics. WHO authorized the vaccine, made by EuBiologics, which also makes the formulation now used, last week. The new version, called Euvichol-S, is a simplified formula that uses fewer ingredients, is cheaper, and can be made more quickly than the old version. The vaccine was shown to be help preventing the diarrheal disease in late stage research conducted in Nepal. WHO’s approval means donor agencies like the vaccines alliance Gavi and UNICEF can now buy it for poorer countries. Leila Pakkala, director of UNICEF’s supply division, said in a statement that the agency will be able to boost supplies by more than 25%. |
Family appeals ruling that threw out lawsuit over 2017 BIA shooting death in North DakotaWelcome to stench ground zero: The village where an unspeakable twoLong flu season winds down in USLilly rides Mounjaro, Zepbound to betterDemocrats vow to protect Speaker Mike Johnson from being ousted from officeWelcome to stench ground zero: The village where an unspeakable twoFree child care from higher taxes? These cities subsidize daycareBrazil soccer player Gabriel Barbosa cleared by CAS to play during appeal in doping rules caseJudge clears former Kentucky secretary of state Alison Lundergan Grimes of ethics chargesJudge clears former Kentucky secretary of state Alison Lundergan Grimes of ethics charges